š¬ Current Disease Focus:
Task Progress: 0%
š„ Active Problem Solvers
0
š Experts collaborating globally
ā” Current Task Assignment
š§¬ Genetic Analysis
š Matching experts to specific tasks
š Resource Allocation by Research Phase:
š Data Analysis
š§Ŗ Experimental Design
š¬ Clinical Trials
š Treatment Development
EBO-PEP is a multicentre, multi-epidemic, phase III, comparative, controlle...
Status
Not Yet Recruiting
Location
National Institute for Biomedical Research (INRB)
Start Date
2026-09
Trial ID
NCT06841614
LA rVSVĪG-ZEBOV-GP -02-PED is a Phase 1/2, randomized, controlled open labe...
Status
Completed
Location
Centre de Recherches MƩdicales de LambarƩnƩ
Start Date
2021-04-09
Trial ID
NCT05130398
A Phase 1 Randomized, Observer Blind, Placebo-controlled, Dose-escalation a...
Status
Recruiting
Location
George Washington University
Start Date
2026-03-27
Trial ID
NCT07425821
Treatments Being Tested
A Phase 1, Single-blind, Placebo-controlled, Dose-escalation Clinical Trial...
Status
Completed
Location
Benchmark Research
Start Date
2023-06-19
Trial ID
NCT05724472
Treatments Being Tested
In this study 30 healthy adult participants will receive a single dose of a...
Status
Active Not Recruiting
Location
The Hope Clinic of the Emory Vaccine Center
Start Date
2024-08-06
Trial ID
NCT06100913
A Phase 1 Randomized, Double-blinded, Placebo-controlled, Dose-escalation C...
Status
Unknown
Location
George Washington University
Start Date
2021-06-23
Trial ID
NCT04794218
Treatments Being Tested
The aim of this study is to investigate the persistence of the vaccine indu...
Status
Completed
Location
MRC - University of Glasgow Centre for Virus Research
Start Date
2017-05-17
Trial ID
NCT03140774
Treatments Being Tested
This study will provide insight into whether cardiac function changes with ...
Status
Recruiting
Location
University of Texas Health Science Center at San Antonio
Start Date
2024-01-16
Trial ID
NCT06108076
Treatments Being Tested
The goal of this clinical trial is to test the safety and immunogenicity of...
Status
Completed
Location
Cenexel ACT (Anaheim Clinical Trials)
Start Date
2024-01-26
Trial ID
NCT06221813
Treatments Being Tested
This study is a multi-center, open label, randomized phase 3b trial to asse...
Status
Withdrawn
Location
University Hospital Frankfurt (KGU)
Start Date
2026-06
Trial ID
NCT05959421
Treatments Being Tested